The reliability of an arabic version of the self-administered standardized chronic respiratory disease questionnaire (CRQ-SAS)

BMC Pulmonary Medicine

Research Article

Mohamed S Al Moamary¹  Hani M Tamim¹ 

[1] College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia;

关键词: Quality of Life;    Pulmonary rehabilitation;    COPD;    Saudi Arabia;   

DOI  :  10.1186/1471-2466-11-21

 received in 2010-09-09, accepted in 2011-04-28,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundTo produce a conceptually equivalent Arabic version to the original Self-Administered Chronic Respiratory Disease Questionnaire with standardized dyspnea domain (CRQ-SAS) and to assess its reliability.MethodsThe study was carried out in two stages: stage I which was the translation of the CRQ-SAS questionnaire from the English to the Arabic language, and stage II which represented the test-retest reliability for patients receiving usual care for COPD who were not yet admitted to the pulmonary rehabilitation program.ResultsForty five patients with stable COPD were enrolled in this study. Strong test-retest reliability was found for the four domains of the CRQ-SAS, with the intra-class correlation coefficient of 0.97 for each of the domains. The association between most parameters and the four domains of CRQ-SAS were not found to be statistically significant, as measured by Pearson correlation. The number of exacerbations was negatively correlated with the dyspnea domain (correlation = -0.36, p-value = 0.02). The disease duration was negatively correlated with the domain fatigue (correlation = -0.35, p-value = 0.02). The correlation between FEV1/FVC ratio and emotion domain was -0.30 (p-value = 0.05). The mastery domain was negatively correlated with FEV1/FVC ratio with a correlation of -0.27 with borderline statistical significance (p-value = 0.07).ConclusionThe Arabic translation of the CRQ-SAS was found to be reliable to assess the quality of life among patients with COPD.

【 授权许可】

CC BY   
© Al Moamary and Tamim; licensee BioMed Central Ltd. 2011